Logo image of UCL

UCLOUDLINK GROUP INC (UCL) Stock Fundamental Analysis

NASDAQ:UCL - Nasdaq - US90354D1046 - ADR - Currency: USD

1.58  -0.02 (-1.26%)

After market: 1.55 -0.03 (-1.9%)

Fundamental Rating

4

UCL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 21 industry peers in the Wireless Telecommunication Services industry. UCL has an average financial health and profitability rating. UCL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

UCL had positive earnings in the past year.
In the past year UCL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: UCL reported negative net income in multiple years.
In multiple years UCL reported negative operating cash flow during the last 5 years.
UCL Yearly Net Income VS EBIT VS OCF VS FCFUCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

UCL has a better Return On Assets (7.01%) than 95.24% of its industry peers.
With an excellent Return On Equity value of 21.08%, UCL belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.64%, UCL belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
ROA 7.01%
ROE 21.08%
ROIC 11.64%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
UCL Yearly ROA, ROE, ROICUCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

With a Profit Margin value of 4.97%, UCL perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
UCL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 4.79%, UCL is in line with its industry, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Operating Margin of UCL has declined.
UCL's Gross Margin of 48.41% is on the low side compared to the rest of the industry. UCL is outperformed by 61.90% of its industry peers.
In the last couple of years the Gross Margin of UCL has grown nicely.
Industry RankSector Rank
OM 4.79%
PM (TTM) 4.97%
GM 48.41%
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
UCL Yearly Profit, Operating, Gross MarginsUCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UCL is creating some value.
The number of shares outstanding for UCL has been increased compared to 1 year ago.
Compared to 5 years ago, UCL has more shares outstanding
UCL has a worse debt/assets ratio than last year.
UCL Yearly Shares OutstandingUCL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
UCL Yearly Total Debt VS Total AssetsUCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -2.07, we must say that UCL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -2.07, UCL is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
UCL has a debt to FCF ratio of 1.34. This is a very positive value and a sign of high solvency as it would only need 1.34 years to pay back of all of its debts.
UCL has a Debt to FCF ratio of 1.34. This is amongst the best in the industry. UCL outperforms 95.24% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that UCL is not too dependend on debt financing.
The Debt to Equity ratio of UCL (0.32) is better than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.34
Altman-Z -2.07
ROIC/WACC1.37
WACC8.49%
UCL Yearly LT Debt VS Equity VS FCFUCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.32 indicates that UCL should not have too much problems paying its short term obligations.
UCL has a Current ratio (1.32) which is comparable to the rest of the industry.
A Quick Ratio of 1.29 indicates that UCL should not have too much problems paying its short term obligations.
UCL has a Quick ratio of 1.29. This is comparable to the rest of the industry: UCL outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.29
UCL Yearly Current Assets VS Current LiabilitesUCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 200.00% over the past year.
Measured over the past 5 years, UCL shows a small growth in Earnings Per Share. The EPS has been growing by 3.89% on average per year.
UCL shows a small growth in Revenue. In the last year, the Revenue has grown by 7.08%.
The Revenue for UCL have been decreasing by -10.37% on average. This is quite bad
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-300%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%3.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-150.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.8%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UCL Yearly Revenue VS EstimatesUCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
UCL Yearly EPS VS EstimatesUCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.56, which indicates a rather expensive current valuation of UCL.
Based on the Price/Earnings ratio, UCL is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.46. UCL is valued slightly cheaper when compared to this.
UCL is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 17.56
Fwd PE N/A
UCL Price Earnings VS Forward Price EarningsUCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UCL is valued cheaper than 100.00% of the companies in the same industry.
UCL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 11.46
EV/EBITDA 1.9
UCL Per share dataUCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.52
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

UCL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UCLOUDLINK GROUP INC

NASDAQ:UCL (6/3/2025, 7:35:30 PM)

After market: 1.55 -0.03 (-1.9%)

1.58

-0.02 (-1.26%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners17.72%
Inst Owner Change13.85%
Ins Owners8.65%
Ins Owner ChangeN/A
Market Cap59.46M
Analysts80
Price Target9.18 (481.01%)
Short Float %4.9%
Short Ratio2.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-297.03%
Min EPS beat(2)-692.08%
Max EPS beat(2)98.02%
EPS beat(4)3
Avg EPS beat(4)-24.75%
Min EPS beat(4)-692.08%
Max EPS beat(4)296.04%
EPS beat(8)5
Avg EPS beat(8)-8.5%
EPS beat(12)6
Avg EPS beat(12)-48.86%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-4.25%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)-0.29%
Min Revenue beat(4)-4.25%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-1.47%
Revenue beat(12)6
Avg Revenue beat(12)-1.15%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)-160%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-24.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.9%
Valuation
Industry RankSector Rank
PE 17.56
Fwd PE N/A
P/S 0.65
P/FCF 11.46
P/OCF 6.47
P/B 2.75
P/tB 2.82
EV/EBITDA 1.9
EPS(TTM)0.09
EY5.7%
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.14
FCFY8.73%
OCF(TTM)0.24
OCFY15.45%
SpS2.43
BVpS0.57
TBVpS0.56
PEG (NY)N/A
PEG (5Y)4.52
Profitability
Industry RankSector Rank
ROA 7.01%
ROE 21.08%
ROCE 19.23%
ROIC 11.64%
ROICexc N/A
ROICexgc N/A
OM 4.79%
PM (TTM) 4.97%
GM 48.41%
FCFM 5.66%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
F-Score6
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.34
Debt/EBITDA 1.04
Cap/Depr 171.74%
Cap/Sales 4.36%
Interest Coverage 22.37
Cash Conversion 136.84%
Profit Quality 113.82%
Current Ratio 1.32
Quick Ratio 1.29
Altman-Z -2.07
F-Score6
WACC8.49%
ROIC/WACC1.37
Cap/Depr(3y)133.27%
Cap/Depr(5y)103.42%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-300%
EPS Next Y-150.5%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.08%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%3.43%
Revenue Next Year4.8%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.9%
EBIT growth 3YN/A
EBIT growth 5Y-12.3%
EBIT Next Year25.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.79%
FCF growth 3YN/A
FCF growth 5Y12.11%
OCF growth 1Y41.17%
OCF growth 3YN/A
OCF growth 5Y9.78%